This article is the second installment in our three-part series, Artificial Intelligence as Intellectual Property or “AI as IP™”, which explores how…
Read More →
Managing partners and other firm leaders might turn their attention to an operating arena on which most have not yet…
Read More →
Through our Venable FDA Pulse series, we provide insight into key developments within the Food and Drug Administration (FDA or the…
Read More →
On December 1, 2025, the Federal Trade Commission (FTC) issued a consent order against Illuminate Education, Inc. (Illuminate), a prominent…
Read More →
Late last week, the U.S. Patent and Trademark Office (USPTO) published three memos addressing its latest policies regarding subject matter…
Read More →
Having participated in mediations as an advocate and as a mediator, I can say that the mediation process lends itself…
Read More →
A diagnosis of T-cell lymphoma after using Dupixent raises serious questions for patients and families. Many want clear answers about…
Read More →
In the November edition of For Your Consumption, our food & beverage digest of court cases and litigation trends affecting…
Read More →
Artificial Intelligence (AI) is rapidly transforming every stage of the employment cycle —from recruiting and selection assessments to performance management…
Read More →
In this weekly update, we summarise the most notable updates in the UK sanctions world. RUSSIA SANCTIONS……By: Mayer Brown…
Read More →